DurĂ£o, Solange http://orcid.org/0000-0001-7028-2638
Effa, Emmanuel
Mbeye, Nyanyiwe
Mthethwa, Mashudu
McCaul, Michael
Naude, Celeste
Brand, Amanda
Blose, Ntombifuthi
Mabetha, Denny
Chibuzor, Moriam
Arikpo, Dachi
Chipojola, Roselyn
Kunje, Gertrude
Vandvik, Per Olav
Esu, Ekpereonne
Lewin, Simon
Kredo, Tamara
Funding for this research was provided by:
European and Developing Countries Clinical Trials Partnership (RIA2020S-3303-GELA)
Article History
Received: 24 July 2023
Accepted: 30 March 2024
First Online: 16 April 2024
Declarations
:
: This study has been approved in the three countries in which it is taking place. In South Africa the study was approved by the SAMRC Human Research Ethics Committee on 19 July 2022 (protocol ID EC011-6/2022). In Nigeria, the study was approved by the National Health Research Ethics Committee (Approval Number NHREC/01/01/2007-30/06/2022). In Malawi, the study was approved by the College of Medicine Research and Ethics Committee (COMREC) (number P.06/22/3665).
: Not applicable.
: The authors declare that they have no competing interests.